A radioimmunoimaging and MIRD dosimetry treatment planning program for radioimmunotherapy

Nuclear Medicine and Biology

Volumn 23, Issue 4, 1996, Pages 525-532

  Erwin, William D ^a   Groch, Mark W ^b   Macey, Daniel J ^c   DeNardo, Gerald L ^d   DeNardo, Sally J ^d   Shen, Sui ^d  

^a SIEMENS CORPORATE RESEARCH   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dosimetry; MIRD; Monoclonal antibodies; Radioimmunoimaging; Radioimmunotherapy; Treatment planning

Indexed keywords

IODINE 131; MONOCLONAL ANTIBODY;

ARTICLE; B CELL LYMPHOMA; BREAST CARCINOMA; CASE REPORT; CONTROLLED STUDY; DOSIMETRY; HUMAN; IMMUNOSCINTIGRAPHY; RADIOIMMUNOTHERAPY; TREATMENT PLANNING;

EID: 0030152864     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(96)00036-4     Document Type: Article

References (45)

1. 1. Bolch W. E., and Poston J. W., Sr. (1995) A revised dosimetric model of the head and brain. J. Nucl. Med. 36, 85P.
2. 2. Cloutier R. J., Watson E. E., Rohrer R. H. and Smith E. M. (1973) Calculating the radiation absorbed dose to an organ. J. Nucl. Med. 14, 53-55.
3. 3. Coffey J. L. and Watson E. E. (1979) Calculating dose from remaining body activity: A comparison of two methods. Med. Phys. 6, 307-308.
4. 4. DeNardo G. L., DeNardo S. J., Macey D. J. and Mills S. L. (1988) Quantitative pharmacokinetics of radiolabeled monoclonal antibodies for imaging and therapy in patients. In Radiolabeled Monoclonal Antibodies for Imaging and Therapy (Edited by Srivastava S. C.), pp. 293-310. Plenum Press, New York.
5. 5. DeNardo G. L., DeNardo S. J., Meares C. F., Kukis D. L., Diril H., McCall M. J., Adams G. P., Mausner L. F., Moody D. C. and Deshpande S. V. (1991) Pharmacokinetics of copper-67 conjugated Lym-1, a potential therapeutic radioimmunoconjugate, in mice and patients with lymphoma. Antibody, Immunoconj. Radiopharm. 4, 777-785.
6. 6. DeNardo G. L., DeNardo S. J., Mills S. L., Lewis J. P., O'Grady L. F. and Levy N. B. (1990) Treatment of B-cell malignancies in patients using I-131 Lym-1. J. Nucl. Med. 31, 723-724.
7. 7. DeNardo G. L., DeNardo S. J., O'Grady L. F., Levy N. B., Adams G. P. and Mills S. L. (1990) Fractionated radioimmunotherapy of B-cell malignancies with I-131 Lym-1, Cancer Res. 50, 1014-1016.
8. 8. DeNardo G. L., Macey D. J., DeNardo S. J., Zhang C. G. and Custer T. R. (1989) Quantitative SPECT of uptake of monoclonal antibodies. Semin. Nucl. Med. 19, 22-32.
9. 9. DeNardo G. L., Raventos A., Hines H. H., Scheibe P. O., Macey D. J., Hays M. T. and DeNardo S. J. (1985) Requirements for a treatment planning system for radioimmunotherapy. Int. J. Radiat. Oncol. Biol. Phys. 11, 335-348.
10. 10. DeNardo G. L., Shen S., DeNardo S. J., Liao S. K., Yu S. and Macey D. J. (1992) Validation of nuclear quantitation of tumor size and I-131 amount in an Alderson phantom by planar imaging. J. Nucl. Med. 33, 925.
11. 11. DeNardo S. J., DeNardo G. L., O'Grady L. F., Hu E., Sytsma V. M., Mills S. L., Levy N. B., Macey D. J., Miller C. H. and Epstein A. L. (1988) Treatment of B-cell malignancies with I-131 Lym-1 monoclonal antibodies. Int. J. Cancer 3, 96-101.
12. 12. DeNardo S. J., DeNardo G. L., O'Grady L. F., Levy N. B., Mills S. L., Macey D. J., McGahan J. P., Miller C. H. and Epstein A. L. (1988) Pilot studies of radioimmunotherapy of B-cell lymphoma and leukemia using I-131 Lym-1 monoclonal antibody. Antibody, Immunoconj. Radiopharm. 1, 17-33.
13. 13. DeNardo S. J., Mirick G. R., Kroger L. A., O'Grady L. F., Erickson K. L., Yuan A., Lamborn K. R., Hellstrom I., Hellstrom K. E. and DeNardo G. L. (1994) The biologic window for chimeric L6 radioimmunotherapy. Cancer 73, 1023-1032.
14. 14. DeNardo S. J., O'Grady L. F., Macey D. J., Kroger L. A., DeNardo G. L., Lamborn K. R., Levy N. B., Mills S. L., Hellstrom I. and Hellstrom K. E. (1991) Quantitative imaging of mouse L-6 monoclonal antibody in breast cancer patients to develop a therapeutic strategy. Nucl. Med. Biol. 18, 621-631.
15. 15. DeNardo S. J., O'Grady L. F., Richman C. M. and DeNardo G. L. (1994) Overview of radioimmunotherapy in advanced breast cancer using I-131 chimeric L6. In Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment (Edited by Ceriani R. I.), pp. 203-211. Plenum Press, New York.
16. 16. Eary J. F., Applebaum F. L., Durack L. and Brown P. (1989) Preliminary validation of the opposing view method for quantitative gamma camera imaging. Med. Phys. 16, 382-387.
17. 17. Erdi A. K., Wessels B. W., DeJager R., Erdi Y. E., Atkins F. B., Yorke E. D., Smith L., Huang E., Smiddy M., Murray J., Varma V. M., McCabe R., McNellis R., John C., Ney A., Nochomovitz L. and Hanna M. G. (1994) Tumor activity confirmation and isodose curve display for patients receiving iodine-131 labeled 16.88 human monoclonal antibody. Cancer 73, 932-944.
18. 18. Giap H. B., Macey D. J., Bayouth J. E. and Boyer A. L. (1995) Validation of a dose-point kernel convolution technique for internal dosimetry. Phys. Med. Biol. 40, 365-381.
19. 19. Glickman S. (1987) Determination of organ volume with SPECT. Proc. SPIE 767, 406-410.
20. 2 fragments of monoclonal antibody in humans. Med. Phys. 11, 778-783.
21. 21. Hosoba M., Wani H., Toyama H., Murata H., and Tanaka E. (1986) Automated body contour detection in SPECT: Effects on quantitative studies. J. Nucl. Med. 27, 1184-1191.
22. 131I radiolabeled antibody uptake in liver, spleen and whole body. Med. Phys. 20, 1667-1674.
23. 23. King M. A., Long D. T. and Brill A. B. (1991) SPECT volume quantitation: Influence of spatial resolution, source size and shape, and voxel size. Med. Phys. 18, 1016-1024.
24. 24. Leichner P. K., Klein J. L., Garrison J. B., Jenkins R. E., Nickoloff E. L., Ettinger D. S. and Order S. E. (1981) Dosimetry of I-131 labeled antiferritin in hepatoma: A model for radioimmunoglobulin dosimetry. Int. J. Radiat. Oncol. Biol. Phys. 7, 323-333.
25. 25. Leichner P. K., Koral K. F., Jaszczak R. J., Green A. J., Chen G. T. Y. and Roesek J. C. (1993) An overview of imaging techniques and physical aspects of treatment planning in radioimmunotherapy. Med. Phys. 20, 569-577.
26. 26. Leszczynski K. W., Shalev S. and Cosby N. S. (1992) The enhancement of radiotherapy verification images by an automated edge detection technique. Med. Phys. 19, 611-621.
27. 27. Loevinger R. and Berman M. (1976) MIRD Pamphlet No. 1, revised. Society of Nuclear Medicine, New York.
28. 28. Long D. T., King M. A. and Sheehan J. (1992) Comparative evaluation of image segmentation methods for volume quantitation in SPECT. Med. Phys. 19, 483-489.
29. 29. Macey D. J., DeNardo G. L. and DeNardo S. J. (1988) Comparison of three boundary detection methods for SPECT using Compton scatter photons. J. Nucl. Med. 29, 203-207.
30. 30. Macey D. J., DeNardo G. L. and DeNardo S. J. (1990) A treatment planning program for radioimmunotherapy. Front. Radiat. Ther. Oncol. 24, 123-131.
31. 31. Macey D. J., Grant E. S., Bayouth J. E., Giap H. B., Danna S. J., Sirisriro R. and Podoloff D.A. (1995) Improved conjugate view quantification of I-131 by subtraction of scatter and septal penetration events with a triple energy window method. Med. Phys. 22, 1637-1644.
32. 32. Macey D. J. and Marshall R. J. (1982) Absolute quantitation of radiotracer uptake in the lungs using a gamma camera. J. Nucl. Med. 23, 731-733.
33. 33. Mortelmans L., Nuyts J., Van Pamel G., Van den Maegdenbergh V., De Roo M. and Suetens P. (1986) A new thresholding method for volume determination by SPECT. Eur. J. Nucl. Med. 12, 284-290.
34. 34. Mut F., Glickman S., Marciano D. and Hawkins R. A. (1988) Optimum processing protocols for volume determination of the liver and spleen from SPECT imaging with technetium-99m sulfur colloid. J. Nucl. Med. 29, 1768-1775.
35. 35. Noz M. E., Kramer E. L., Maguire G. Q. Jr., McGoe S. A. and Sangor J. J. (1993) An integrated approach to biodistribution radiation absorbed dose estimates. Eur. J. Nucl. Med. 20, 165-169.
36. 36. Sgouros G., Barest G., Thekkumthala J., Chiu C., Mohan R., Bigler R. E. and Zanzonico P. B. (1990) Treatment planning for internal radionuclide therapy: Three-dimensional dosimetry for nonuniformly distributed radionuclides. J. Nucl. Med. 31, 1884-1891.
37. 37. Sgouros G., Chiu C., Pentlow K. S., Brewster L. J., Kalagian H., Baldwin B., Daghighian F., Graham M. C., Larson S. M. and Moran R. (1993) Three-dimensional dosimetry for radioimmunotherapy treatment planning. J. Nucl. Med. 34, 1595-1601.
38. 38. Shen S., DeNardo G. L. and DeNardo S. J. (1994) Quantitative bremsstrahlung imaging of yttrium-90 using a Wiener filter. Med. Phys. 21, 1409-1417.
39. 67Cu-2IT-BAT-LYM-1 for radioimmunotherapy. J. Nucl. Med. 37, 146-150.
40. 40. Shulkin B. L., Sisson J. C., Koral K. F., Shapiro B., Wang X. and Johnson J. ( 1988) Conjugate view gamma camera method for estimating tumor uptake of iodine-131 Metaiodobenzylguanidine. J. Nucl. Med. 29, 542-548.
41. 41. Snyder W. S., Ford M. R., Warner G. G. and Watson S. B. (1975) MIRD Pamphlet No. 11. Society of Nuclear Medicine, New York.
42. 42. Stabin M., et al. (1994) MIRDOSE 3. Oak Ridge Associated Universities, Oak Ridge, Tennessee.
43. 43. Thomas S. R., Maxon H. R. and Kereiakes J. G. (1976) In vivo quantitation of lesion radioactivity using external counting methods. Med. Phys. 3, 253-255.
44. 44. Watson E. E., Stabin M. and Bolch W. E. (1984) MIRDOSE, Version 2. Oak Ridge Associated Universities, Oak Ridge, Tennessee.
45. 45. Wessels B. W. and Rogus R. D. (1984) Radionuclide selection and model absorbed close calculations for radiolabeled tumor associated antibodies. Med. Phys. 11, 638-645.